UTR ups its production capability for Electric Vehicle battery material
Battery technology company, UltraCharge Limited (ASX:UTR) announced today it will be upscaling its production of nanotube material at its pilot project with one of the world’s leading fully vertically integrated battery energy storage solution providers, Leclanché SA.
UTR has an MOU with Leclanché to seek cost competitive and large-scale manufacturing of a high-cycling, fast-charging and high energy density battery for the electric vehicle market.
The pilot project involves testing and evaluating its titanium dioxide nanotube technology. The technology will replace graphite in anodes (negative pole) with a nanotube gel material made from titanium dioxide, in lithium batteries. This has the potential to revolutionise the market for lithium batteries by producing a battery that is safe, has a longer lifetime and is fast charging.
Leclanché has partnership with Fastned, a Dutch company that is pioneering the roll-out of fast charging stations for electric vehicles (EVs) in Europe. Leclanché has been tasked with developing the battery storage solution.
Leclanché has also signed an agreement with electric bus, or Ebus, manufacturer Skoda Electric, which will see Leclanché provide Skoda with battery solutions for its eBus expansion strategy.
Additionally, the increased nanotube material production capability will assist in meeting growing demand from other end users.
UltraCharge has already demonstrated significant progress in the successful synthesis of its nanofiber anode material using its pilot reactor, producing 50g/day of anode material. To meet the requirements for stage 2 of the project, UTR has ordered a 55L reactor to increase production capacity by 25 times.
The new equipment will enable the production of at least 250kgs of anode material per year. This will be more than enough to meet the higher demand from Leclanché as it continues to test the material in its battery manufacturing plant.
Those considering this stock shouldn’t make assumptions regarding future sales, nor should they base investment decisions on performances to date. Those considering this stock should seek independent financial advice.
This new reactor at UTR’s facility is an important step in delivering on its milestones and business strategy. It will help progress its partnership with Leclanché, and provide additional capacity to meet demand from new customers.
UTR is currently in discussions with several potential clients and remains focused on its strategy to bring its anode technology to market, specifically for use in electric vehicles along with other industrial applications.
UTR CEO, Kobi Ben-Shabat, said “We are making excellent progress on our pilot project with Leclanché, and I am confident that the new reactor will allow us to upscale our production processes and deliver the quantities needed for Leclanché to build a battery prototype for testing. I look forward to updating the market on the results of the testing and the next stage of the project”.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.